Position in NBIX
as of Mar 31, 2026
· filed May 11, 2026
Position Value
$253,336
-$20,537 QoQ
Shares Held
1,923
-0.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
7 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Claret Asset Management Corp holds $23,258,930 across 6 Drug Manufacturers - Specialty & Generic names. NBIX ranks #5 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INDV |
Indivior Pharmaceuticals, Inc.
|
707,267 | $21,557,498 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
806 | $477,941 | |
| 3 | ELAN |
Elanco Animal Health Inc
|
16,017 | $383,286 | |
| 4 | VTRS |
Viatris Inc
|
26,710 | $360,852 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
This page
|
1,923 | $253,336 | |
| 6 | ZTS |
Zoetis Inc.
|
1,912 | $226,017 |
All Filings in NBIX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $253,336 | 1,923 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $273,873 | 1,931 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $256,614 | 1,828 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $233,029 | 1,854 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $203,931 | 1,494 | Shares | Sole | 2025-02-13 | |
| 2024-03-31 | $200,121 | 1,451 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $206,204 | 1,565 | Shares | Sole | 2024-02-12 | |
| No filing history on record for this holder in this stock. | ||||||